Controlled-release oxycodone

DRUG3 trials

Sponsors

Instituto Nacional de Cancer, Brazil, Sun Yat-sen University

Conditions

Adverse EffectsLiver CancerNasopharyngeal CarcinomaOpioid Analgesic Adverse ReactionPainPain PostoperativePostoperative Nausea

Phase 3

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

CompletedNCT03059238

Sun Yat-sen UniversityLiver Cancer, Pain Postoperative

Start: 2016-09-30End: 2019-03-31Updated: 2019-08-13

Unknown Phase

Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery

CompletedNCT01834898

Instituto Nacional de Cancer, BrazilAdverse Effects, Opioid Analgesic Adverse Reaction, Pain +1

Start: 2010-10-31End: 2012-10-31Updated: 2013-04-18

Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2016-05-31End: 2018-06-30Target: 70Updated: 2017-11-29

Related Papers

Celecoxib versus parecoxib versus oxycodone in pain control for transcatheter chemoembolization in patients with hepatocellular carcinoma.

Journal of Clinical Oncology2020-02-01